These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn's disease patients on maintenance treatment with adalimumab. Ferreiro-Iglesias R; Barreiro-de Acosta M; Lorenzo-Gonzalez A; Dominguez-Muñoz JE Scand J Gastroenterol; 2016; 51(4):442-7. PubMed ID: 26595391 [TBL] [Abstract][Full Text] [Related]
33. Low fecal calprotectin predicts clinical remission in Crohn's disease patients: the simple answer to a challenging question. Monteiro S; Dias de Castro F; Leite S; Moreira MJ; Cotter J Scand J Gastroenterol; 2019 Jan; 54(1):49-54. PubMed ID: 30663515 [TBL] [Abstract][Full Text] [Related]
34. Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy. Yamamoto T; Shiraki M; Bamba T; Umegae S; Matsumoto K Int J Colorectal Dis; 2014 Apr; 29(4):485-91. PubMed ID: 24343276 [TBL] [Abstract][Full Text] [Related]
35. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660 [TBL] [Abstract][Full Text] [Related]
37. Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease. Vinding KK; Elsberg H; Thorkilgaard T; Belard E; Pedersen N; Elkjaer M; Marker D; Carlsen K; Burisch J; Munkholm P Inflamm Bowel Dis; 2016 Feb; 22(2):336-44. PubMed ID: 26535869 [TBL] [Abstract][Full Text] [Related]
38. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients. Nunes T; Etchevers MJ; Sandi MJ; Pinó Donnay S; Grandjean T; Pellisé M; Panés J; Ricart E; Iovanna JL; Dagorn JC; Chamaillard M; Sans M PLoS One; 2014; 9(1):e84957. PubMed ID: 24416322 [TBL] [Abstract][Full Text] [Related]
39. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients. Foster AJ; Smyth M; Lakhani A; Jung B; Brant RF; Jacobson K World J Gastroenterol; 2019 Mar; 25(10):1266-1277. PubMed ID: 30886509 [TBL] [Abstract][Full Text] [Related]
40. Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study. Negm M; Bahaa A; Farrag A; Lithy RM; Badary HA; Essam M; Kamel S; Sakr M; Abd El Aaty W; Shamkh M; Basiony A; Dawoud I; Shehab H BMC Gastroenterol; 2022 Apr; 22(1):203. PubMed ID: 35462542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]